Antioxidant and antitumor activities of Capparis spinosa L. and the related mechanisms

  • Authors:
    • Lei Yu
    • Jinghui Yang
    • Xin Wang
    • Bo Jiang
    • Yongxue Sun
    • Yubin Ji
  • View Affiliations

  • Published online on: November 16, 2016     https://doi.org/10.3892/or.2016.5249
  • Pages: 357-367
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The ‘ethnodrug’ Capparis spinosa L. has several pharmacological activities. First, it was found in previous experiments that an ethyl acetate extract of Capparis spinosa L. (CSE) exhibited antioxidant activity. In order to further research this finding, the present study investigate the blood biochemical indices, injury, energy metabolism, oxidative damage and mitochondrial membrane potential (Δψm) level of cardiac cells to study the effect of CSE on doxorubicin-induced cardiac toxicity. CSE had protective effects on the cardiac toxic effect of doxorubicin, and decreased the activity of lactic dehydrogenase (LDH) and creatine kinase (CK). CSE increased the ability of myocardial tissue to scavenge free radicals, inhibited lipid peroxidation, increased recovery activity of antioxidant enzymes, adjusted the energy metabolism of myocardial tissue, inhibited the generation of a large number of ROS in the cells, raised the level of Δψm, and improved the metabolism of free radicals. CSE demonstrated protective effects on doxorubicin-induced myocardial damage. Second, the quaternary ammonium hydroxide of Capparis spinosa L. (CSQAH) was found to possess antitumor activity, such as antiproliferative and apoptosis-induced effects on HepG2 cells. We investigated the regulatory mechanism of HepG2 apoptosis induced by CSQAH. Laser scanning confocal microscope and Fluo-3/AM staining were utilized to detect the Ca2+ concentration in the HepG2 cells. A microplate reader was used to measure the changes in Ca2+-Mg2+-ATP enzyme. Then, flow cytometry was applied to analyze the activity of ROS and the expression levels of Bcl-2 and Bax. As a result, different concentrations of CSQAH increased the concentration of Ca2+ in the cytoplasm in a dosage-dependent manner. CSQAH decreased the Ca2+‑Mg2+‑ATPase activity in the HepG2 cells. The levels of ROS in the CSQAH groups were significantly higher than the level in the control group. Flow cytometric analysis showed that the Bcl-2 expression levels in the CSQAH-treated groups were downregulated, while Bax expression levels were upregulated, and the effects were dosage-dependent. The regulatory mechanism of HepG2 cell apoptosis induced by CSQAH involved the increase in Ca2+ concentration and ROS levels, a decrease in Ca2+-Mg2+-ATPase activity in the HepG2 cells, and downregulation of anti-apoptotic Bcl-2 expression, and upregulation of apoptotic Bax expression. In summary, the present study demonstrated the antioxidant and antitumor activities of CSE which may suppress tumor growth and alleviate the side-effects of DOX, which may facilitate tumor treatment in a dual manner.

Introduction

Capers are a common ingredient in Mediterranean cuisine, particularly Cypriot, Italian and Maltese recipes. Capparis spinosa L. (CSE), the caper bush, also called cishangan, Euphorbia lathyris L. and Capparis masaikai Levl., is a perennial plant that bears round, fleshy leaves and large white to pinkish-white flowers. CSE is found in the wild in the Mediterranean, East Africa, Madagascar, Southwestern and Central Asia, Himalayas, the Pacific Islands, Indomalaya and Australia. The plant is best known for the edible flower buds (capers), often used as a seasoning, and the fruit (caper berries), both of which are usually consumed pickled. The salted and pickled caper bud (called simply a caper) is often used as a seasoning or garnish. The mature fruit of the caper shrub are prepared similarly and marketed as caper berries. The buds are picked, then pickled in salt, or a salt and vinegar solution, and drained. Other parts of the Capparis plants are used in the manufacture of medicines and cosmetics. The shrubby plant is many-branched, with alternate leaves, thick and shiny, round to ovate. The flowers are complete, sweetly fragrant and showy, with four sepals and four white to pinkish-white petals. Intense flavor is developed as mustard oil is released from each caper bud. This enzymatic reaction leads to the formation of rutin, often seen as crystallized white spots on the surfaces of individual caper buds. In Greek popular medicine, a herbal tea made of caper root and young shoots is considered beneficial against rheumatism (16).

CSE contains glucosinolates (glucocapparin, glucocleomin, glucoiberin, glucopangulin and singrin), flavonoids and choline, coumarins, saponins and tannins. Instruction exists on the use of sprouts, roots, leaves and seeds in the treatment of strangury and inflammation. Different flavonoids have been identified in the caper bush and capers: rutin (quercetin 3-rutinoside), quercetin 7-rutinoside, quercetin 3-glucoside-7-rhamnoside, kaempferol 3-rutinoside, astragalin and kaempferol 3-rhamnorutinoside. Capers contain more quercetin/weight than any other plant (7). Selenium is present in capers at high concentrations in comparison with other vegetable products. Furthermore, CSE extract was reported to be rich in flavonoids such as kaempferol, rutin, quercetin and quercetin derivatives, which are known to have anti-allergic, anti-inflammatory, antioxidant, anti-fungal, anti-bacterial anti-hepatotoxic, anti-diabetic, antiproliferative and antitumor properties. Recently, the effect of plant extracts on melanogenesis has been reported and compounds, such as glycyrrhizin, quercetin and scoparone, were found to stimulate melanogenesis (819).

Doxorubicin (DOX) is a potent broad-spectrum chemotherapeutic agent that is highly effective in treating patients with acute lymphoblastic leukemia, Hodgkins lymphoma, aggressive non-Hodgkins lymphomas, breast and ovarian carcinoma, and many solid tumors. The therapeutic activity of DOX is achieved through the processes of intercalating into DNA, inhibiting topoisomerase II, and preventing DNA and RNA synthesis. Unfortunately, its clinical chemotherapeutic use is limited by its severe toxicity on the heart when the accumulative dose reaches a threshold. The cardiotoxicity particularly subchronic and delayed cardiotoxicity is manifested by dose-dependent cardiomyopathy and refractory congestive heart failure with the unique pathological changes being distention of the endoplasmic reticulum, swelling of mitochondria, cytoplasmic vacuolization and myofibrillar disarray, and loss (sarcopenia) in cardiomyocytes as well as apoptosis. A great deal of research has been carried out to investigate the molecular mechanisms by which DOX selectively impairs the heart. As a result, a number of mechanisms were proposed although most of them are attributable to the basis that DOX increases the production of ROS in cardiomyocytes (2025). It was found in previous experiments that ethyl acetate extract of CSE has antioxidant activity and improves the oxidative damage symptoms observed by morphological changes of pathology and hematoxylin and eosin (H&E) staining. The major mechanism of heart dysfunction induced by oxidative stress (free radical damage) that is responsible for DOX cardiotoxicity is the formation of ROS, which can harm membrane lipids and other cellular components, leading to cardiomyocyte apoptosis and death. In order to further research this issue, the present study investigated blood biochemical indices, injury, energy metabolism, oxidative damage and mitochondrial membrane potential (Δψm) level of cardiac cells to study the effect of CSE on DOX-induced cardiac toxicity. Thus, the first part of the study was designed to investigate whether CSE has any protective effect on oxidative damage induced by DOX and to explore whether or not CSE can be used as an adjuvant therapy for the long-term clinical use of DOX. Our theory basis can make a foundation for the following research.

In a previous study, we demonstrated that CSE inhibited tumor cell growth and the main constituent responsible for the antitumor activity is alkaloid (26). The quaternary ammonium hydroxide of Capparis spinosa L. (CSQAH) is one of the water-soluble alkaloids which is obtained by means of ammonium reineckate. It also inhibited tumor cell growth and induced cell apoptosis. However, the molecular mechanisms associated with the apoptosis of human hepatocellular carcinoma HepG2 cells by CSQAH is not clear and systematically understood. In the second part of the study, we therefore utilized flow cytometry (FCM) and laser scanning confocal microscopy (LSCM) to detect Ca2+ concentrations, Ca2+-Mg2+-ATP enzyme activity and ROS, Bcl-2 and Bax levels to investigate the regulatory mechanism of HepG2 cell apoptosis induced by CSQAH.

In summary, the present study demonstrated the antioxidant and antitumor activities of CSE which may suppress tumor growth and alleviate the side-effects of DOX, which may facilitate tumor treatment in a dual manner.

Materials and methods

Antioxidant activity of CSE and its protective effect on oxidative damage induced by DOX
Animals and treatment

The present study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The protocol was approved by the Ethics Committee of the Animal Experiments of the Heilongjiang University of Chinese Medicine (permit no. 2013–004). All surgery was performed under sodium pentobarbital anesthesia, and all efforts were made to minimize suffering of the animals.

Kunming mice (animal certificate no. POO101009; provided by the Animal Experiment of Heilongjiang University of Chinese Medicine), half male and female, were randomly divided into five groups (n=12/group): normal, DOX and CSE groups; CSE-L, CSE-M and CSE-H (40, 80 and 120 mg/kg). The numbers of each group fit the statistical requirements. Food and water were provided freely and the mice were sacrificed by cervical dislocation in accordance with ethical requirements. Each mouse was weighed before administration. The normal group was orally administered normal saline (0.01 ml/g, daily), and the DOX groups were intraperitoneal injected with DOX hydrochloride (15 mg/kg) once on day 5. The CSE groups received different doses of CSE extract orally for five consecutive days and were intraperitoneally injected with a single dose of DOX hydrochloridex (15 mg/kg) 2 h after the CSE extract treatment on day 5, and then CSE was continued to be administered for 2 days.

Screening of antioxidant fraction by EPPH

The fruits of CSE (5 kg) were extracted with 95% ethanol. Evaporation of the solvent under reduced pressure provided the condensed ethanol extract, which was then extracted by petroleum ether, chloroform, ethyl acetate and n-butyl alcohol in turn. The five factions were assessed for their antioxidant activities by EPPH method (27).

Effect of CSE on injury and energy metabolism induced by DOX

The serum of all test groups was prepared. The levels of lactic dehydrogenase (LDH) and creatine kinase (CK) were measured by ultraviolet spectrophotometric method according to the instruction manual of the reagent (28). Then, the cardiac tissue of all test groups was prepared. The ATPase activities were measured by ultraviolet spectrophotometric method according to the instruction manual of the reagent (29).

Effect of CSE on oxidative damage induced by DOX

The cardiac tissues of all test groups were prepared. The level of malondialdehyde (MDA) was determinated by ultraviolet spectrophotometric method according to the instruction manual of the reagent (30). Secondly, determination of intracellular ROS levels was performed by measuring a fluorescent product formed by DCFHDA (10 µmol/l). The samples were incubated in an incubator at 37°C for 40 min, and then washed with phosphate-buffered saline (PBS) three times. The cells were made into a suspension using 300 ml PBS and put through a 200 mesh screen. The relative amount of fluorescent product was monitored by FCM at 48 and 535 nm (31). Finally, antioxidation enzyme indicators in the serum were measured. The mice were sacrificed under the influence of anesthesia. The heart was excised immediately, rinsed in ice-cold normal saline, blotted between two filter papers, and weighed. Heart tissue (0.5 g) was triturated and dropped into 10% tissue homogenate according to the volume and weight ratio. The cell debris was removed using centrifugation at 3,000 rpm for 15 min. The cell supernatants were collected, and then diluted with normal saline in proportion to the required concentration of tissue homogenate. The protein content of the cell lysates was determined using the Bradford assay. T-AOC of blood measurement, superoxide dismutase (SOD), glutathione (GSH) and catalase (CAT) of heart tissue homogenate assay were carried out according to the kit illustrations using ultraviolet spectrophotometer.

Effect of CSE on Δψm levels of cardiac cells induced by DOX

The purification of cardiac cells was carried out by counting with a hemocytometer. Cardiac cells (lx106) were placed in dimethyl sulfoxide (DMSO), and incubated in an incubator at 37°C for 40 min with Rh123 for testing Δψm, and then washed with PBS three times. The 300 ml PBS suspension was filtrated through 200 mesh size screen. Cells (104) were collected and measured with FCM, excitation and maximum absorption at 488 and 530 nm (32).

Antitumor activity of CSQAH and its apoptosis induction on HepG2 cells
Cell culture

Human gastric carcinoma cell line SGC-7901 was cultured in RPMI-1640 medium with 10% calf serum at 37°C in a 5% CO2 incubator.

Measurement of Ca2+ by LSCM

HepG2 cells in a logarithmic growth phase were inoculated in 6-well plates. After 24 h, 1 ml of drugs was added to each hole. CSQAH was added at concentrations of 100, 200 and 400 µg/ml, respectively. The final concentration of the positive control group (HCPT) was 5 µg/ml. The control group received the same volume of RPMI-1640 culture media. After 48 h, the cell suspension was collected. The cells were washed with PBS and fixed with 4 µg/ml Fluo-3/AM 200 ml. Then, the cells were incubated for 1 h at 37°C in the dark. The cells were washed one time and suspended with 400 µl PBS, and then the cells were detected with LSCM (33).

Analysis of Ca2+-Mg2+-ATP enzyme by adenosine triphosphatase assay kit

HepG2 cells in the logarithmic growth phase were inoculated in a 5-ml culture bottle. After incubating for 24 h, the cells were treated with 1 ml of drugs to each bottle (the doses same as above). After 24 h, the cells were digested with trypsin and washed with PBS two times. This operation is carried out according to the adenosine triphosphatase assay kit manual. Absorbance was measured with a microplate reader at 636 nm, zeroed with distilled water (34).

Detection of ROS using FCM

HepG2 cells in the logarithmic growth phase were inoculated in 6-well plates. After 24 h, 1 ml of the drugs was added to each hole (the doses same as above). After 48 h, the cells were collected and suspended in DCFH-DA (diluted 1:1,000 with RPMI-1640 without serum, the final concentration was 10 µmol/l). Then, the cells were incubated for 1 h at 37°C and the cells were washed three times with RPMI-1640 without serum. After filtration with 300 mesh strainer, the cells were analyzed by FCM (35).

Analysis of Bcl-2 and Bax protein by FCM

HepG2 cells in the logarithmic growth phase were inoculated in a culture bottle. After incubating for 24 h, the cells were treated with 1 ml of drugs in each bottle (the doses same as above). After 24 h, the cells were collected and fixed with 40 g/l paraformaldehyde 2 ml for 40 min. Then, the cells were washed twice with PBS and treated with 0.1% Triton X-100 1 ml for 15 min, washed twice with PBS again, closed with 1% of BSA 1 ml for 1 h, and then centrifuged. The cells were treated with primary antibodies specific for Bcl-2 or Bax (diluted 1:200), respectively. Then, incubation was carried out for 1 h at 37°C. The mixture was centrifuged and the supernatant was removed and washed with PBS, and then treated with the secondary antibodies (diluted 1:50). The cells were incubated at room temperature for 30 min in the dark and centrifuged. The supernatant was removed, while the cells were suspended in 800 µl of PBS. After being filtrated with 300 mesh strainer, the cells were analyzed by FCM (3638).

Statistical analysis

Differences in proliferation between different groups were analyzed using one-way ANOVA. Statistical analysis was performed using SPSS 19.0 software. P<0.01 was considered to indicate a statistically significant difference. The results are expressed as mean ± SD.

Results

Antioxidant activity of CSE and its protective effect on oxidative damage induced by DOX
The antioxidant fraction of CSE

From the EPPH method, the most antioxidant activity of CSE was the ethyl acetate fraction shown in Table I.

Table I.

Effect of the extracts on DPPH-free radical scavenging.

Table I.

Effect of the extracts on DPPH-free radical scavenging.

Extracts50% Effective concentrationAntiradical efficiency/(ml/mg)
Petroleum ether0.991.98
Chloroform1.062.13
Ethyl acetate3.136.25
N-butyl alcohol1.172.34
Water1.513.02

[i] The samples were assessed by the EPPH method. This method can be used for the quantitative analysis of samples (water, soil, sediment and sludge) for their antioxidant activities.

Effect of CSE on injury and energy metabolism induced by DOX

The DOX group exhibited significantly an increased LDH value (P<0.01). Compared with the DOX group, CSE groups exhibited decreased levels of LDH (P<0.01). Compared with the normal group, the CSE groups had increased levels of LDH (P<0.01) (Table II). The DOX group exhibited a significantly increased CK value compared with the normal group (P<0.01). Compared with the DOX group, the CSE groups exhibited decreased levels of CK (P<0.01). The CSE groups exhibited increased levels of CK, compared with the normal group (P<0.01).

Table II.

Effect of CSE on LDH and CK values in blood (n=10, mean ± SD).

Table II.

Effect of CSE on LDH and CK values in blood (n=10, mean ± SD).

GroupDose (mg/kg)LDH (U/l)CK (U/ml)
Control0 1,887.82±147.65419.13±32.43
DOX15 3,898.03±128.72a 809.04±34.33a
CSE-L40 3,374.61±116.66a,b 574.65±30.75a,b
CSE-M80 2,754.62±103.81a,b 496.80±22.95a,b
CSE-H120 2,187.48±132.51a,b 504.30±28.91a,b

{ label (or @symbol) needed for fn[@id='tfn2-or-37-01-0357'] } The serum of all test groups was measured by ultraviolet spectrophotometric method to obtain the values of LDH and CK. Compared with control

a P<0.01; compared with the DOX group

b P<0.01. CSE, Capparis spinosa L.; LDH, lactic dehydrogenase; CK, creatine kinase.

The DOX group exhibited decreased levels of Na+K+-ATPase and Ca2+-ATPase compared with the normal group (P<0.01). The CSE groups showed an increase in the level of Na+K+-ATPase when compared with the DOX alone treated mice. No significant difference in Na+K+-ATPase was observed between the CSE-L group and the DOX group (P>0.05), while the levels of Na+K+-ATPase in the CSE-M and CSE-M groups were significantly increased compared with the DOX group (P<0.05). The CSE groups showed an increase in the level of Ca2+-ATPase when compared with the DOX group. A significant difference was observed in the CSE-L group when compared to the DOX group (P<0.05), and significant differences were also observed in the CSE-M and CSE-H groups (P<0.01). The level of Ca2+-ATPase in the CSE-L group was significantly lower compared with the normal group (P<0.01). No significant difference was observed in CSE-M and CSE-H groups when compared with the normal group (P>0.01; Table III).

Table III.

Effect of CSE on ATP activities in cardiac tissue (n=10) mean ± SD.

Table III.

Effect of CSE on ATP activities in cardiac tissue (n=10) mean ± SD.

GroupDose (mg/kg) Na+K+-ATPase (µmolPi/mgprot/h) Ca2+-TPase (µmolPi/mgprot/h)
Control06.92±0.515.66±0.39
DOX15 5.88±0.60a 4.68±0.52a
CSE-L40 6.25±0.63a 5.12±0.42a,b
CSE-M80 6.41±0.46b 5.38±0.44c
CSE-H120 6.49±0.63b 5.49±0.41c

{ label (or @symbol) needed for fn[@id='tfn5-or-37-01-0357'] } The ATPase activities in the cardiac tissue were measured by ultraviolet spectrophotometric method according to the instruction manual of reagent. Compared with control group

a P<0.01; compared with DOX group

b P<0.05

c P<0.01. CSE, Capparis spinosa L.; DOX, doxorubicin.

Effect of CSE on oxidative damage induced by DOX

MDA levels in the cardiac tissues showed that the MDA level in the DOX group was increased, compared with the normal group. There was a significant differences(P<0.01). The CSE groups showed a significant decrease in the level of MDA (P<0.01) when compared with the DOX alone treated mice. The levels of MDA in the CSE groups were significantly increased compared with the normal group (P<0.01; Table IV).

Table IV.

Effect of CSE on MDA levels in cardiac tissue (n=10, mean ± SD).

Table IV.

Effect of CSE on MDA levels in cardiac tissue (n=10, mean ± SD).

GroupDose (mg/kg)MDA (nmol/mgprot)
Control04.82±0.19
DOX15 9.19±0.37a
CSE-L40 7.34±0.50a,b
CSE-M80 6.67±0.20a,b
CSE-H120 6.10±0.23a,b

{ label (or @symbol) needed for fn[@id='tfn9-or-37-01-0357'] } The level of MDA in the cardiac tissues was determined by ultraviolet spectrophotometric method according to the instruction manual of the reagent. Compared with the control group

a P<0.01; compared with the DOX group

b P<0.01. CSE, Capparis spinosa L.; MDA, malondialdehyde; DOX, doxorubicin.

The results showed that the DOX group, compared with the normal group, exhibited decreased levels of ROS. The CSE groups showed a decrease in the levels of ROS when compared with the DOX group. The CSE groups showed an increase in the level of ROS when compared with the normal group (Fig. 1).

In these tests, compared with normal group, the DOX group exhibited a significantly decreased T-AOC value (P<0.01). CSE groups, compared with the DOX group, exhibited significantly increased T-AOC values (P<0.01). T-AOC values in the CSE groups were significantly decreased compared with the normal group (P<0.01). Mice treated with DOX alone showed a significant (P<0.01) decrease in the activity of SOD in the heart as compared to the normal control mice. The CSE groups showed a significant (P<0.05) increase in the activity of SOD when compared with the DOX alone treated mouse. The SOD level in the CSE-H group was significantly decreased compared with the normal group (P<0.05). No significant difference was observed in the CSE-L and CSE-M groups when compared with the normal group (P>0.05). GSH levels in the cardiac tissues showed that the DOX group, compared with the normal group, exhibited a decreased level of GSH. There was a significant difference (P<0.01). The CSE groups showed a significant (P<0.01) increase in the levels of GSH when compared with the DOX alone treated mouse. The CSE groups compared with normal group had a significant difference (P<0.01). Mice treated with DOX alone showed a significant (P<0.01) decrease in the activity of CAT in the heart as compared to the normal control mice. CSE groups showed a significant (P<0.01) increase in the activity of CAT when compared with the DOX alone treated mouse. The CSE-L group showed a significant difference when compared with the normal group (P<0.01). No significant differences were observed in the CSE-M and CSE-H groups when compared with the normal group (P>0.05; Table V).

Table V.

Effect of CSE on T-AOC, SOD, CAT and GSH-Px (n=10, mean ± SD).

Table V.

Effect of CSE on T-AOC, SOD, CAT and GSH-Px (n=10, mean ± SD).

GroupDose (mg/kg)T-AOCSOD (U/mg prot)CAT (U/mg prot)GSH-Px (mg/g prot)
Control0294.17±10.97181.20±13.88381.64±23.4611.88±1.26
DOX15 200.75±6.67b 162.20±14.54b 317.71±23.38b 8.31±0.99b
CSE-L40 239.56±7.91b,d 176.91±11.96c 351.31±28.66b,d 9.58±0.62b,d
CSE-M80 253.31±6.46b,d 178.53±13.51c 360.67±24.55d 10.16±0.63b,d
CSE-H120 250.60±6.84b,d 166.25±13.62c,a 369.82±23.58d 9.50±0.68b,d

{ label (or @symbol) needed for fn[@id='tfn12-or-37-01-0357'] } T-AOC of blood measurement, SOD, GSH and CAT of heart tissue homogenate assay were determined by ultraviolet spectrophotometer. Compared with the control

b P<0.01; compared with DOX group

d P<0.01. CSE, Capparis spinosa L.; T-AOC, total antioxidation ability; SOD, superoxide dismutase; CAT, catalase; GSH, glutathione; GSH-Px, GSH-peroxidase.

Effect of CSE on the Δψm levels in cardiac cells induced by DOX

The results showed that the DOX group, compared with the normal group, exhibited a decreased level of Δψm. The CSE groups showed an increase in the levels of Δψm when compared with the DOX group. The CSE groups showed an increase in the level of Δψm when compared with the normal group (Fig. 2).

Antitumor activity of CSQAH and its apoptosis induction on HepG2 cells
Observation of CSQAH-induced change in [Ca2+] in the HepG2 cells

The brightness of the green fluorescence was greater with increasing concentrations of CSQAH. Different concentrations of CSQAH increased the concentration of Ca2+ in the cytoplasm in a dosage-dependent manner. HepG2 cells exhibited an increase in Ca2+ levels compared with the blank control group (P<0.01). As shown in Table VI and Fig. 3, the result showed that the concentration of Ca2+ increased with the increase in the concentration of CSQAH. After 48 h, the green fluorescence of HCPT was significantly enhanced.

Table VI.

Effect of CSQAH on activity of Ca2+-Mg2+-ATPase.

Table VI.

Effect of CSQAH on activity of Ca2+-Mg2+-ATPase.

GroupDose (µg/ml) Ca2+-Mg2+-ATPase
Control00.104±0.020
HCPT5 0.067±0.024b
CSQAH-L100 0.079±0.003a
CSQAH-M200 0.065±0.004b
CSQAH-H400 0.037±0.002b

{ label (or @symbol) needed for fn[@id='tfn15-or-37-01-0357'] } After incubation with 100, 200 and 400 µg/ml CSQAH for 24 h, the activity of Ca2+-Mg2+-ATPase in the cells was measured with a microplate reader at 636 nm. Compared with the control group

a P<0.05

b P<0.01. CSQAH, quaternary ammonium hydroxide of Capparis spinosa L.; HCPT, positive control group.

Effect of CSQAH on activity of Ca2+-Mg2+-ATPase

With the increasing concentration of CSQAH, the optical density (OD) was decreased. Thus, the Ca2+-Mg2+-ATPase enzyme activity in the HepG2 cells was decreased. The result is shown in Table VII. Each increasing concentration of CSQAH decreased the activity of Ca2+-Mg2+-ATPase enzyme. When the CSQAH groups were compared with the control group, there was a significantly difference (P<0.05 and P<0.01). The Ca2+-Mg2+-ATPase enzyme activity of the HCPT group was lower than that noted in the control group (P<0.01).

Table VII.

Effect of CSQAH on variation of [Ca2+] in the HepG-2 cells.

Table VII.

Effect of CSQAH on variation of [Ca2+] in the HepG-2 cells.

GroupDose (µg/ml)FI of [Ca2+]
Control039.31±2.16
HCPT5 49.84±2.89a
CSQAH-L100 60.37±3.91b
CSQAH-M200 79.84±5.54b
CSQAH-H400 108.52±5.69b

{ label (or @symbol) needed for fn[@id='tfn18-or-37-01-0357'] } HepG2 cells were inoculated with 100, 200 and 400 µg/ml CSQAH for 24 h. Then, the cells were dyed using Fluo-3/AM and detected with a laser scanning confocal microscope. FI of [Ca2+] represents the fluorescence intensity of 50 cells for each figure. Compared with the control group

a P<0.05

b P<0.01. CSQAH, quaternary ammonium hydroxide of Capparis spinosa L.; HCPT, positive control group.

Effect of CSQAH on the level of ROS

Flow cytometric analysis showed that CSQAH increased the levels of ROS in te HepG2 cells. The production of ROS was decreased in a dose-dependent manner (Fig. 4).

Effect of CSQAH on the expression levels of Bcl-2 and Bax

When HepG2 cells were treated with CSQAH for 48 h, Bcl-2 and Bax were detected by FCM. The results are shown in Figs. 5 and 6. Significant changes in Bax and Bcl-2 expression (an increase in Bax and a decrease in Bcl-2) were observed in the CSQAH-treated HepG2 cells in a dose-dependent manner.

Discussion

Antioxidant activity of CSE and its protective effect on oxidative damage induced by DOX

After determination of the activity of lactic dehydrogenase (LDH) and creatine kinase (CK) in serum, the doxorubicin (DOX) group exhibited significantly increased LDH and CK values compared with the normal group (P<0.01). In the Capparis spinosa L. (CSE) groups, the level of LDH and CK were lower than the levels in the DOX group (P<0.01). These results indicated that DOX decreased the level of myocardial injury (LDH and CK); thus, CSE protected against DOX-induced myocardial injury. Previous pathology experimental observation found that DOX causes serious tissue and cell damage. After tissues and cells are damaged, enzymes are released into the bloodstream (39,40). DOX can alter the norms of blood biochemistry, and CSE can significantly inhibit DOX-induced increases in serum activity of LDH and CK. According to the results of the present study, it can be concluded that CSE protects myocardial tissue and cells in mice.

The damage of free radicals can reduce the activity of Na+K+-ATpase and Ca2+-ATPase leading to abnormal energy metabolism. The activity of Na+K+-ATPase and Ca2+-ATPase was reduced in the DOX group, while DOX initiated membrane lipid peroxidation (41). MDA is the metabolite of lipid peroxidation products, which could interfere with metabolic to cellular acidosis. An increase in Na+-Ca2+ exchange, also accelerates the Ca2+ internal flow, then induces intracellular calcium overload. DOX can induce calcium overload, so the mitochondria need to consume a large amount of ATP to intake excessive-free Ca2+ to reduce the levels of ATP in the cell. Reduction of ATP also causes sarcoplasmic reticulum Ca2+ATPase-power shortage, which reduces the ability to absorb Ca2+. After further aggravation of calcium overload, a vicious circle may occur in the cell. CSE can increase the activity of ATPase and maintain the stability of the biofilm structure, protecting the biological membrane from oxidative damage. MDA is a sign of lipid peroxidation. MDA not only reflects the degree of free radicals produced, but also reflects the degree of lipid peroxidation (42,43). The MDA levels in the CSE groups were significantly lower than the corresponding values in the DOX group, which indicated that CSE could significantly guard against lipid peroxidation. CSE has a protective effect on rat myocardial tissue.

In the present study, the level of intracellular ROS production was monitored by flow cytometry (FCM) (44,45). The results showed that the DOX group exhibited increased production of ROS compared with the normal group, whereas treatment with CSE significantly decreased the generation of ROS. These results suggested that CSE can balance ROS production and neutralization and inhibit DOX-induced intracellular ROS generation and protect cells from damage.

Through determination of the full blood total antioxidation ability (T-AOC), the DOX group exhibited significantly decreased T-AOC values (P<0.01). The CSE groups exhibited significantly increased T-AOC values compared with the DOX group (P<0.01). The results indicated that administration of CSE can improve body total antioxidation ability. Administration of DOX to rats significantly altered the cardiac activities of CAT, SOD and GSH-peroxidase (GSH-Px), which reflect the changes in free radicals in myocardial tissues. The mechanism of DOX-induced cardiotoxicity involves the generation of ROS (46,47). For increasing production of ROS by oxidative stress, the activity of the cardiac antioxidant enzyme SOD is significantly reduced. The main cellular damages caused by ROS included lipid peroxidation and MDA were formed in hearts. CSE has obvious ability to scavenge free radicals, which can be attributed to the enhancment of the activity of antioxidant enzymes (CAT, SOD and GSH-Px). DOX-induced cardiotoxicity caused the activity of cardiac antioxidant enzymes CAT, SOD and GSH-Px which were significantly reduced. Administration of CSE to the mice significantly increased the cardiac activities of CAT, SOD, and GSH-Px as compared to the DOX group, indicating the protective effect of CSE. The antioxidant effect of CSE has been shown to decrease DOX-induced cardiotoxicity as indicated by the ability to inhibit the production of free radicals, thus accelerating free radical consumption and reducing the consumption of antioxidant enzymes.

The formation of ROS which could harm membrane lipids, reduces the fluidity of membrane and increases the cell membrane permeability, causing Δψm decrease (4850). This could cause oxidative damage to proteins, resulting in protein denaturation and crosslink, and a change in enzyme activity (51). The level of Δψm was monitored by FCM. The results showed that the DOX group exhibited a decreased level of Δψm compared with the normal group. The CSE groups exhibited decreased levels of Δψm compared with the DOX group. CSE prevented ROS-mediated peroxidative damage to the mitochondrial membrane and opened MPTP, and increased mitochondrial membrane fluidity.

Antitumor activity of CSQAH and its apoptosis induction in HepG2 cells

Ca2+ plays a pivotal role in the physiology and biochemistry of organisms and cells. They play an important role in signal transduction pathways, where they act as a secondary messenger. Ca2+ make their entrance into the cytoplasm either from outside the cell through the cell membrane via calcium channels or from some internal calcium storages. Ca2+ could damage cells when they enter in excessive numbers. Excessive entry of calcium into a cell may damage it or even cause it to undergo apoptosis, or death by necrosis (52,53). In this experiment, the Ca2+-specific molecular probe Fluo-3/AM was used to carry CSQAH at different concentrations to treat HepG2 cells, and LCSM was used to observe changes in [Ca2+] in the cells. The result of the research showed that the strength of green fluorescence increased with the increase in the concentration of CSQAH. The HepG2 cells exhibited increase Ca2+ levels compared with the control group, significantly (P<0.01). This shows that the concentration of Ca2+ may increase with the increase in the concentration of CSQAH. On the one hand, this suggests that CSQAH can effect the calcium channels in HepG2 cells, which in turn leads to the rise of the concentration of Ca2+ in the cell. On the other hand, it could be that CSQAH activates endoplasmic reticulum, which is due to the stimulation of a specific Ca2+ release (54,55). When the concentration of Ca2+ is increased, endogenous nuclease is activated, cutting the DNA chain, inducing apoptosis of cells. Thereby, we indicate that the mechanism of apoptosis which was induced by CSQAH is possibly related to Ca2+ release. The result of the microplate reader showed that the OD value was decreased with the increasing dose, which indicated that the amount of inorganic phosphorus declined. It also demonstrated that the activity of Ca2+-Mg2+-ATPase enzyme was indirectly decreased. Experimental data showed that each group of CSQAH could decrease the activity of Ca2+-Mg2+-ATPase enzyme. There was a significantly difference in the CSQAH groups compared with the control group (P<0.05). The decrease in Ca2+-Mg2+-ATPase enzyme activity confirmed that the increase in Ca2+ concentration was inevitable, while Ca2+ overload induced apoptosis.

ROS are chemically reactive molecules containing oxygen. Examples include oxygen ions and peroxides. ROS are formed as a natural byproduct of the normal metabolism of oxygen and have important roles in cell signaling and homeostasis. ROS are constantly generated and eliminated in the biological system and are required to drive regulatory pathways. Under normal physiologic conditions, cells control ROS levels by balancing the generation of ROS with their elimination by a scavenging system. However, under oxidative stress conditions, excessive ROS may damage cellular proteins, lipids and DNA, leading to fatal lesions in cell that contribute to carcinogenesis. Ultra-ROS could damage DNA, RNA, and proteins. This may result in significant damage to cell structures. Cumulatively, this is known as oxidative stress (5658). From the results obtained, with the increase in CSQAH concentration, the level of ROS was increased when compared with the control group (P<0.01). This illustrates that CSQAH could increase the level of ROS in HepG2 cells. The result indicates the accumulation of ROS, which play an important role in the mitochondrial control of apoptosis induced by CSQAH.

Apoptosis regulator Bcl-2 is a family of evolutionarily related proteins. These proteins govern mitochondrial outer membrane permeabilization (MOMP) and could be either pro-apoptotic (Bax, BAD, Bak and and Bok) or anti-apoptotic (including Bcl-2, Bcl-xL and Bcl-w). There are a number of theories concerning how the Bcl-2 gene family exerts their pro-apoptotic or anti-apoptotic effect. An important theory states that this is achieved by activation or inactivation of an inner mitochondrial permeability transition pore, which is involved in the regulation of matrix Ca2+, pH and voltage. It is also believed that certain Bcl-2 family proteins induce or inhibit the release of Cyt-c into the cytosol, which activate caspase-9 and −3, leading to apoptosis (59,60). When HepG2 cells were treated with CSQAH for 48 h, FCM analysis showed that Bcl-2 expression levels in the CSQAH-treated groups were downregulated, while Bax expression levels were upregulated, and the effects were dosage-dependent. The result showed that CSQAH could downregulate anti-apoptotic proteins.

In conclusion, the present study revealed the antioxidant and antitumor activities of CSE. On the one hand, the ethyl acetate extract of CSE showed antioxidant activity using the DPPH method to determine free radical elimination ability. CSE had protective effects on cardiac toxicity of DOX, decreasing the activity of LDH and CK. CSE improved the ability of myocardial tissue to scavenge free radicals, inhibited the lipid peroxidation, recovered activity of antioxidant enzymes, adjusted the energy metabolism of myocardial tissue, inhibited the generation of a large number of ROS in the cells, raised the level of Δψm, and improved the metabolism of free radicals. CSE had protective effects on DOX-induced myocardial damage. Moreover, the quaternary ammonium hydroxide of Capparis spinosa L. (CSQAH) induced HepG2 cells apoptosis by increasing Ca2+ concentrations and ROS levels, decreasing the Ca2+-Mg2+-ATPase activity in HepG2 cells, and downregulating anti-apoptotic Bcl-2 expression while upregulating apoptotic Bax expression. In summary, the present study demonstrated the antioxidant and antitumor activities of CSE which may suppress tumor growth and alleviate the side-effects of DOX, which may facilitate tumor treatment in a dual manner.

Acknowledgements

The present study was supported in part by the Open Research Program for Key Laboratory of College of Heilongjiang Province (China) (CPAT-2012003), the Natural Science Project of Department of Education of Heilongjiang Province (China) (12541205), the Innovation Talents Project of Science and Technology of Harbin City (China) (2014RFQXJ154), the Doctoral Research Project of Harbin University of Commerce (12DL008), and the Graduate Students Innovative Research Project of Harbin University of Commerce (YJSCX2015-390HSD).

References

1 

Germanò MP, De Pasquale R, D'Angelo V, Catania S, Silvari V and Costa C: Evaluation of extracts and isolated fraction from Capparis spinosa L. buds as an antioxidant source. J Agric Food Chem. 50:1168–1171. 2002.

2 

Orphanos PI: Germination of caper (Capparis spinosa L.) seeds. J Hortic Sci. 58:267–270. 1983. View Article : Google Scholar

3 

Higton RN and Akeroyd JR: Variation in Capparis spinosa L. in Europe. Bot J Linn Soc. 106:104–112. 1991.

4 

Castro Ramos RD and Nosti Vega M: The caper (Capparis spinosa L.). Grasas Aceites. 38:183–186. 1987.

5 

Aytaç Z and Kınaci Ceylan GA: Yield and some morphological characteristics of caper (Capparis spinosa L.) population cultivated at various slopes in Aegean ecological conditions. Pak J Bot. 2:591–596. 2009.

6 

Kulisic-Bilusic T, Schmöller I, Schnäbele K, Siracusa L and Ruberto G: The anticancerogenic potential of essential oil and aqueous infusion from caper (Capparis spinosa L.). Food Chem. 1:261–267. 2012. View Article : Google Scholar

7 

Tlili N, Khaldi A, Triki S and Munné-Bosch S: Phenolic compounds and vitamin antioxidants of caper (Capparis spinosa). Plant Foods Hum Nutr. 65:260–265. 2010. View Article : Google Scholar : PubMed/NCBI

8 

Bonina F, Puglia C, Ventura D, Aquino R, Tortora S, Sacchi A, Saija A, Tomaino A, Pellegrino ML and de Caprariis P: In vitro antioxidant and in vivo photoprotective effects of a lyophilized extract of Capparis spinosa L buds. J Cosmet Sci. 53:321–335. 2002.PubMed/NCBI

9 

Siracusa L, Kulisic-Bilusic T, Politeo O, Krause I, Dejanovic B and Ruberto G: Phenolic composition and antioxidant activity of aqueous infusions from Capparis spinosa L. and Crithmum maritimum L. before and after submission to a two-step in vitro digestion model. J Agric Food Chem. 59:12453–12459. 2011.

10 

Abraham SV Issac, Palani A, Ramaswamy BR, Shunmugiah KP and Arumugam VR: Antiquorum sensing and antibiofilm potential of Capparis spinosa. Arch Med Res. 42:658–668. 2011. View Article : Google Scholar : PubMed/NCBI

11 

al-Said MS, Abdelsattar EA, Khalifa SI and el-Feraly FS: Isolation and identification of an anti-inflammatory principle from Capparis spinosa. Pharmazie. 43:640–641. 1988.PubMed/NCBI

12 

Boga C, Forlani L, Calienni R, Hindley T, Hochkoeppler A, Tozzi S and Zanna N: On the antibacterial activity of roots of Capparis spinosa L. Nat Prod Res. 25:417–421. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Gadgoli C and Mishra SH: Antihepatotoxic activity of p-methoxy benzoic acid from Capparis spinosa. J Ethnopharmacol. 66:187–192. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Huseini HF, Hasani-Rnjbar S, Nayebi N, Heshmat R, Sigaroodi FK, Ahvazi M, Alaei BA and Kianbakht S: Capparis spinosa L. (Caper) fruit extract in treatment of type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 21:447–452. 2013.

15 

Lam SK and Ng TB: A protein with antiproliferative, antifungal and HIV-1 reverse transcriptase inhibitory activities from caper (Capparis spinosa) seeds. Phytomedicine. 16:444–450. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Eddouks M, Lemhadri A and Michel JB: Hypolipidemic activity of aqueous extract of Capparis spinosa L. in normal and diabetic rats. J Ethnopharmacol. 98:345–350. 2005. View Article : Google Scholar

17 

Ali-Shtayeh MS and Abu Ghdeib SI: Antifungal activity of plant extracts against dermatophytes. Mycoses. 42:665–672. 1999. View Article : Google Scholar : PubMed/NCBI

18 

Zhou HF, Xie C, Jian R, Kang J, Li Y, Zhuang CL, Yang F, Zhang LL, Lai L, Wu T, et al: Biflavonoids from caper (Capparis spinosa L.) fruits and their effects in inhibiting NF-kappa B activation. J Agric Food Chem. 59:3060–3065. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Ziyyat A, Legssyer A, Mekhfi H, Dassouli A, Serhrouchni M and Benjelloun W: Phytotherapy of hypertension and diabetes in oriental Morocco. J Ethnopharmacol. 58:45–54. 1997. View Article : Google Scholar : PubMed/NCBI

20 

Houghton PJ, Hylands PJ, Mensah AY, Hensel A and Deters AM: In vitro tests and ethnopharmacological investigations: Wound healing as an example. J Ethnopharmacol. 100:100–107. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Wu JB, Ye SF, Liang CL, Li YC, Yu YJ, Lai JM, Lin H, Zheng J and Zhou JY: Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury. J Ethnopharmacol. 151:1124–1132. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Unverferth DV, Magorien RD, Leier CV and Balcerzak SP: Doxorubicin cardiotoxicity. Cancer Treat Rev. 9:149–164. 1982. View Article : Google Scholar : PubMed/NCBI

23 

Alexander J, Dainiak N, Berger HJ, Goldman L, Johnstone D, Reduto L, Duffy T, Schwartz P, Gottschalk A, Zaret BL, et al: Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. N Engl J Med. 300:278–283. 1979. View Article : Google Scholar : PubMed/NCBI

24 

Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR and Freireich EJ: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med. 96:133–139. 1982. View Article : Google Scholar : PubMed/NCBI

25 

Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M and Voipio-Pulkki LM: Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 60:1789–1792. 2000.PubMed/NCBI

26 

Ji YB and Yu L: N-butanol extract of Capparis spinosa L. induces apoptosis primarily through a mitochondrial pathway involving mPTP open, cytochrome C release and caspase activation. Asian Pac J Cancer Prev. 15:9153–9157. 2014.

27 

Hossain MA and Rahma SMM: Total phenolics flavonoids and antioxidant activity of tropical fruit pineapple. Food Res Int. 3:672–676. 2011. View Article : Google Scholar

28 

Wallimann T, Wyss M, Brdiczka D, Nicolay K and Eppenberger HM: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J. 281:21–40. 1992. View Article : Google Scholar : PubMed/NCBI

29 

Obradovic M, Bjelogrlic P, Rizzo M, Katsiki N, Haidara M, Stewart AJ, Jovanovic A and Isenovic ER: Effects of obesity and estradiol on Na+/K+-ATPase and their relevance to cardiovascular diseases. J Endocrinol. 218:R13–R23. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Pryor WA and Stanley JP: Letter: A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem. 40:3615–3617. 1975.

31 

Bani S, Gautam M, Sheikh FA, Khan B, Satti NK, Suri KA, Qazi GN and Patwardhan B: Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry. J Ethnopharmacol. 107:107–115. 2006. View Article : Google Scholar : PubMed/NCBI

32 

Jaiswal PK, Gupta J, Shahni S and Thakur IS: NADPH oxidase-mediated superoxide production by intermediary bacterial metabolites of dibenzofuran: A potential cause for trans-mitochondrial membrane potential (ΔΨm) collapse in human hepatoma cells. Toxicol Sci. 147:17–27. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Hoffman A, Goetz M, Vieth M, Galle PR, Neurath MF and Kiesslich R: Confocal laser endomicroscopy: Technical status and current indications. Endoscopy. 38:1275–1283. 2006. View Article : Google Scholar : PubMed/NCBI

34 

Fernando KC and Barritt GJ: Pinocytosis in 2,5-di-tert-butylhydroquinone-stimulated hepatocytes and evaluation of its role in Ca2+ inflow. Mol Cell Biochem. 162:23–29. 1996. View Article : Google Scholar : PubMed/NCBI

35 

Devasagayam TPA, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS and Lele RD: Free radicals and antioxidants in human health: Current status and future prospects. J Assoc Physicians India. 52:794–804. 2004.PubMed/NCBI

36 

Lo K, Brinkman RR and Gottardo R: Automated gating of flow cytometry data via robust model-based clustering. Cytometry A. 73:321–332. 2008. View Article : Google Scholar : PubMed/NCBI

37 

Julius MH, Masuda T and Herzenberg LA: Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. Proc Natl Acad Sci USA. 69:1934–1938. 1972. View Article : Google Scholar : PubMed/NCBI

38 

Basiji DA, Ortyn WE, Liang L, Venkatachalam V and Morrissey P: Cellular image analysis and imaging by flow cytometry. Clin Lab Med. 27653–670. (viii)2007. View Article : Google Scholar : PubMed/NCBI

39 

Schlattner U, Tokarska-Schlattner M and Wallimann T: Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta. 1762:164–180. 2006. View Article : Google Scholar : PubMed/NCBI

40 

Vlkovicová J, Javorková V, Mézesová L, Pechánová O, Andriantsitohaina R and Vrbjar N: Dual effect of polyphenolic compounds on cardiac Na+/K+-ATPase during development and persistence of hypertension in rats. Can J Physiol Pharmacol. 87:1046–1054. 2009. View Article : Google Scholar : PubMed/NCBI

41 

Ketzer LA, Arruda AP, Carvalho DP and de Meis L: Cardiac sarcoplasmic reticulum Ca2+-ATPase: Heat production and phospholamban alterations promoted by cold exposure and thyroid hormone. Am J Physiol Heart Circ Physiol. 297:H556–H563. 2009. View Article : Google Scholar : PubMed/NCBI

42 

Del Rio D, Stewart AJ and Pellegrini N: A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 15:316–328. 2005. View Article : Google Scholar : PubMed/NCBI

43 

Marnett LJ: Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res. 424:83–95. 1999. View Article : Google Scholar : PubMed/NCBI

44 

Buranrat B and Connor JR: Cytoprotective effects of ferritin on doxorubicin-induced breast cancer cell death. Oncol Rep. 34:2790–2796. 2015.PubMed/NCBI

45 

Han D, Williams E and Cadenas E: Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space. Biochem J. 353:411–416. 2001. View Article : Google Scholar : PubMed/NCBI

46 

Sheng B, Xu G, Chen D, Chen J, Gao W, Gao W, Li X, Yang J, Liu F, Gao Y, et al: TT-AOC, MDA, SOD, CAT and IL-6 levels in rat pulmonary edema induced by hypobaric hypoxia. J Third Mil Med Univ. 23:2364–2367. 2012.

47 

Kirby AJ and Schmidt RJ: The antioxidant activity of Chinese herbs for eczema and of placebo herbs - I. J Ethnopharmacol. 56:103–108. 1997. View Article : Google Scholar : PubMed/NCBI

48 

Szliszka E and Krol W: Soy isoflavones augment the effect of TRAIL-mediated apoptotic death in prostate cancer cells. Oncol Rep. 26:533–541. 2011.PubMed/NCBI

49 

Fernandez-Sanz C, Ruiz-Meana M, Castellano J, Miro-Casas E, Nuñez E, Inserte J, Vázquez J and Garcia-Dorado D: Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes. Thromb Haemost. 113:441–451. 2015. View Article : Google Scholar : PubMed/NCBI

50 

Watanabe T, Saotome M, Nobuhara M, Sakamoto A, Urushida T, Katoh H, Satoh H, Funaki M and Hayashi H: Roles of mitochondrial fragmentation and reactive oxygen species in mitochondrial dysfunction and myocardial insulin resistance. Exp Cell Res. 323:314–325. 2014. View Article : Google Scholar : PubMed/NCBI

51 

Gauthier LD, Greenstein JL, Cortassa S, O'Rourke B and Winslow RL: A computational model of reactive oxygen species and redox balance in cardiac mitochondria. Biophys J. 105:1045–1056. 2013. View Article : Google Scholar : PubMed/NCBI

52 

Slinchenko NM: Effect of fluoroaluminate on the ATP-hydrolysing and Ca2+-transporting activity of the purified Ca2+, Mg2+-ATPase of myometrium cell plasma membranes. Ukr Biokhim Zh. 75:95–98. 2003.(In Ukrainian).

53 

Toledo-Maciel A, Gonçalves-Gomes S, de Gouveia Castex M and Vieyra A: Progressive inactivation of plasma membrane (Ca2++Mg2+)ATPase by Cd2+ in the absence of ATP and reversible inhibition during catalysis. Biochemistry. 37:15261–15265. 1998. View Article : Google Scholar : PubMed/NCBI

54 

Monaco G, Decrock E, Arbel N, van Vliet AR, La Rovere RM, De Smedt H, Parys JB, Agostinis P, Leybaert L, Shoshan-Barmatz V, et al: The BH4 domain of anti-apoptotic Bcl-XL, but not that of the related Bcl-2, limits the voltage-dependent anion channel 1 (VDAC1)-mediated transfer of pro-apoptotic Ca2+ signals to mitochondria. J Biol Chem. 290:9150–9161. 2015. View Article : Google Scholar : PubMed/NCBI

55 

Barrezueta LF, Oshima CT, Lima FO, De Oliveira Costa H, Gomes TS, Neto RA and De Franco MF: The intrinsic apoptotic signaling pathway in gastric adenocarcinomas of Brazilian patients: Immunoexpression of the Bcl-2 family (Bcl-2, Bcl-x, Bak, Bax, Bad) determined by tissue microarray analysis. Mol Med Rep. 3:261–267. 2010. View Article : Google Scholar : PubMed/NCBI

56 

Rada B and Leto TL: Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol. 15:164–187. 2008. View Article : Google Scholar : PubMed/NCBI

57 

Sumiyoshi H, Matsushita A, Nakamura Y, Matsuda Y, Ishiwata T, Naito Z and Uchida E: Suppression of STAT5b in pancreatic cancer cells leads to attenuated gemcitabine chemoresistance, adhesion and invasion. Oncol Rep. 35:3216–3226. 2016.PubMed/NCBI

58 

Park SY, Kim JY, Lee SM, Jun CH, Cho SB, Park CH, Joo YE, Kim HS, Choi SK and Rew JS: Capsaicin induces apoptosis and modulates MAPK signaling in human gastric cancer cells. Mol Med Rep. 9:499–502. 2014.PubMed/NCBI

59 

Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, et al: X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:335–341. 1996. View Article : Google Scholar : PubMed/NCBI

60 

Sucha L, Hroch M, Rezacova M, Rudolf E, Havelek R, Sispera L, Cmielova J, Kohlerova R, Bezrouk A and Tomsik P: The cytotoxic effect of α-tomatine in MCF-7 human adenocarcinoma breast cancer cells depends on its interaction with cholesterol in incubation media and does not involve apoptosis induction. Oncol Rep. 30:2593–2602. 2013.PubMed/NCBI

Related Articles

Journal Cover

January-2017
Volume 37 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yu L, Yang J, Wang X, Jiang B, Sun Y and Ji Y: Antioxidant and antitumor activities of Capparis spinosa L. and the related mechanisms. Oncol Rep 37: 357-367, 2017.
APA
Yu, L., Yang, J., Wang, X., Jiang, B., Sun, Y., & Ji, Y. (2017). Antioxidant and antitumor activities of Capparis spinosa L. and the related mechanisms. Oncology Reports, 37, 357-367. https://doi.org/10.3892/or.2016.5249
MLA
Yu, L., Yang, J., Wang, X., Jiang, B., Sun, Y., Ji, Y."Antioxidant and antitumor activities of Capparis spinosa L. and the related mechanisms". Oncology Reports 37.1 (2017): 357-367.
Chicago
Yu, L., Yang, J., Wang, X., Jiang, B., Sun, Y., Ji, Y."Antioxidant and antitumor activities of Capparis spinosa L. and the related mechanisms". Oncology Reports 37, no. 1 (2017): 357-367. https://doi.org/10.3892/or.2016.5249